Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Zakai

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology|August 15, 2022
Geographic disparities in cardiovascular mortality among patients with myelodysplastic syndromes: A population-based analysisDiego Adrianzen-Herrera, Andrew D Sparks, Aditi Shastri, et al.
Stroke|October 26, 2020
Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United StatesDebora Kamin Mukaz, Neil A Zakai, Salvador Cruz-Flores, et al.
Thrombosis and Haemostasis|May 1, 2010
Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism EtiologyNeil A Zakai, Pamela L Lutsey, Aaron R Folsom, et al.
The American Journal of Cardiology|October 3, 2019
Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention TrialTimothy B Plante, Stephen P Juraschek, Neil A Zakai, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysisDiego Adrianzen-Herrera, Pamela L Lutsey, Katherine Giorgio, et al.
The AIDS Reader|January 9, 2008
Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorderJennifer A Yates, Neil A Zakai, Rogers C Griffith, et al.
Thrombosis and Haemostasis|June 12, 2018
Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)Neil A Zakai, Suzanne E Judd, Brett Kissela, et al.
The Oncologist|October 5, 2020
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from ImmunotherapyMansour Gergi, Kara K Landry, Steven Ades, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2021
Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosisNeil A Zakai, Rob F Walker, Richard F MacLehose, et al.
Research and Practice in Thrombosis and Haemostasis|May 12, 2021
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleedingRichard F MacLehose, Neil A Zakai, Rob F Walker, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology|August 15, 2022
Geographic disparities in cardiovascular mortality among patients with myelodysplastic syndromes: A population-based analysisDiego Adrianzen-Herrera, Andrew D Sparks, Aditi Shastri, et al.
Stroke|October 26, 2020
Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United StatesDebora Kamin Mukaz, Neil A Zakai, Salvador Cruz-Flores, et al.
Thrombosis and Haemostasis|May 1, 2010
Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism EtiologyNeil A Zakai, Pamela L Lutsey, Aaron R Folsom, et al.
The American Journal of Cardiology|October 3, 2019
Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention TrialTimothy B Plante, Stephen P Juraschek, Neil A Zakai, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysisDiego Adrianzen-Herrera, Pamela L Lutsey, Katherine Giorgio, et al.
The AIDS Reader|January 9, 2008
Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorderJennifer A Yates, Neil A Zakai, Rogers C Griffith, et al.
Thrombosis and Haemostasis|June 12, 2018
Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)Neil A Zakai, Suzanne E Judd, Brett Kissela, et al.
The Oncologist|October 5, 2020
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from ImmunotherapyMansour Gergi, Kara K Landry, Steven Ades, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2021
Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosisNeil A Zakai, Rob F Walker, Richard F MacLehose, et al.
Research and Practice in Thrombosis and Haemostasis|May 12, 2021
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleedingRichard F MacLehose, Neil A Zakai, Rob F Walker, et al.
Pageof 17